Article information
Full text is only aviable in PDF
Bibliografía
[1.]
E. Culotta, D. Koshland.
NO news is good news The molecule of the year.
Science, 258 (1992), pp. 1.862-1.865
[2.]
G. Cremona, A.T. Dihn Xuan, T.W. Higenbottam.
Endotheliumderived relaxing factor and the pulmonary circulation.
Lung, 169 (1991), pp. 185-202
[3.]
M. Hogman, C. Frostell, H. Arnberg, G. Hedenstierna.
Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit.
Eur Respir J, 6 (1993), pp. 177-180
[4.]
S.A. Hkaritonov, D. Yates, R.A. Robbins, R. Logan-Sinclair, E.A. Shinebourne, P.J. Barnes.
Increased nitric oxide in exhaled air of asthmathic patients.
Lancet, 343 (1994), pp. 133-135
[5.]
R. Rossaint, K.R. Falke, F. López, K. Slama, U. Pison, W.M. Zapol.
Inhaled nitric oxide for the adult respiratory distress syndrome.
N Engl J Med, 328 (1993), pp. 399-405
[6.]
J.D. Roberts, D.M. Polaner, P. Lang, W.M. Zapol.
Inhaled nitric oxide in persistent pulmonary hypertension on the newborn.
Lancet, 340 (1992), pp. 818-819
[7.]
S. Moneada, R.M.J. Palmer, E.A. Higgs.
Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication.
Biochem Pharmacol, 38 (1989), pp. 1.709-1.715
[8.]
B. Gaston, J.M. Drazen, J. Loscalzo, J. Stamler.
The biology of nitrogen oxides in the airways.
Am J Respir Crit Care Med, 149 (1994), pp. 538-551
[9.]
R.M.J. Palmer, D.S. Ashton, S. Moncada.
Vascular endothelial cells synthesize nitric oxide from L-arginine.
Nature, 333 (1988), pp. 664-666
[10.]
S. Moneada.
The L-arginine: nitric oxide pathway.
Acta Physiol Scand, 145 (1992), pp. 201-227
[11.]
S. Moneada, R.M.J. Palmer, E.A. Higgs.
Nitric oxide: physiology, pathophysiology and pharmacology.
Pharmacol Rev, 43 (1991), pp. 109-142
[12.]
W. Martin, R.F. Furchgott, G.M. Villani, D. Jotbianandan.
Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor.
J Pharmacol Exp Ther, 237 (1986), pp. 539-547
[13.]
R.J. Grygleski, R.M.J. Palmer, S. Moneada.
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
Nature, 320 (1986), pp. 454-456
[14.]
S. Moneada, A. Higgs.
The L-arginine-nitric oxide pathway.
N Engl J Med, 329 (1993), pp. 2.002-2.012
[15.]
W. Martín, G.M. Villani, D. Jothianandan, R.F. Furchgott.
Selective blockade of endothelium-dependent and glyceril trinitrateinduced relaxation by hemoglobin and by methilene blue in the rabbit aorta.
J Pharmacol Exp Ther, 232 (1985), pp. 708-716
[16.]
Borland CDR, Harmes K, Cracknell N, Mack D, Higenbottam TW. Methaemoglobin levels in smokers and non-smokers. Arch Environ Health 40: 330-333.
[17.]
C. Frostell, H. Blomqvist, G. Hedenstierna, J. Lundberg, W.M. Zapol.
Inhaled nitric oxide reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation.
Anesthesiology, 78 (1993), pp. 427-435
[18.]
J. Pepke-Zaba, T.W. Higenbottam, A.T. Dinh-Xuan, D. Stone, J. Wallwork.
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.
Lancet, 338 (1991), pp. 1.173-1.174
[19.]
R.N. Channick, R.C. Hoch, J.W. Newhart, F.W. Johnson, C.M. Smith.
Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis.
Am J Respir Crit Care Med, 149 (1994), pp. 811-814
[20.]
NIOSH recommendations for occupational safety and health standars. Morb Mortal Wkly Res 1988; 37 Supl S-7: 21.
[21.]
L. Foubert, B. Fleming, R. Latimer, M. Jonas, C. Oduro, C. Borland, T. Higenbottam.
Safety guidelines for use of nitric oxide.
Lancet, 339 (1992), pp. 1.615-1.616
[22.]
J.D. Roberts, D.M. Polaner, P. Lang, W.M. Zapol.
Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
Lancet, 340 (1992), pp. 818-819
[23.]
R.F. Furchgott, J.V. Zawadzki.
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
Nature, 288 (1980), pp. 373-376
[24.]
L.J. Ignarro, G.M. Buga, K.S. Wood, R.E. Byrns.
Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide.
Proc Natl Acad Sci USA, 84 (1987), pp. 9.265-9.269
[25.]
R.M.J. Palmer, A.G. Ferridge, S. Moneada.
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Nature, 327 (1987), pp. 524-526
[26.]
D.M. Rodman, N.F. Voelkel.
Regulation of vascular tone.
The Lung, pp. 1.105-1.116
[27.]
E.D. Robin, J. Theodore, C.M. Burke.
Hypoxic pulmonary vasoconstriction persists in the human transplanted lung.
Clin Sci, 73 (1987), pp. 283-287
[28.]
M.I. Christie, T.M. Griffith, M.J. Lewis.
A comparison of basal and agonist-stimulated release of endothelium-derived relaxing factor from different arteries.
Br J Pharmacol, 98 (1989), pp. 397-406
[29.]
L.J. Ignarro, R.E. Byrns, G.M. Buga, K.S. Wood.
Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP.
Am J Physiol, 253 (1987), pp. 1.074-1.082
[30.]
P. Vallance, J. Collier, S. Moneada.
Effects of endothelium derived nitric oxide on peripheral arteriolar tone in man.
Lancet, 2 (1989), pp. 0.997-1.000
[31.]
B.A. Shapiro, R.A. Harrison, R.D. Cane, R.K. Templin.
Hipoxemia y oxigenoterapia.
Manejo clínico de los gases sanguíneos., pp. 116-117
[32.]
A.G.N. Agustí, J.A. Barberà, J. Roca, P.D. Wagner, R. Guitart, R. Rodriguez-Roisin.
Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease.
Chest, 97 (1990), pp. 268-275
[33.]
C. Frostell, M.D. Fratacci, J.C. Wain, R. Jones, W.M. Zapol.
Inhaled nitric oxide, a selective pulmonary vasodilator reversing hypoxic pulmonary Vasoconstriction.
Circulation, 83 (1991), pp. 2.038-2.047
[34.]
S.F. Liu, D.E. Crawley, P.J. Barnes, T.W. Evans.
Endotheliumderived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats.
Am Rev Respir Dis, 143 (1991), pp. 32-37
[35.]
A.T. Dinh-Xuan, T.W. Higenbottam, C.A. Clelland, J. Pepke-Zaba, G. Cremona, A.Y. Butt, et al.
Impairment of endotheliumdependent pulmonary-artery relaxation in chronic obstructive pulmonary disease.
N Engl J Med, 324 (1991), pp. 1.539-1.547
[36.]
J.A. Barberà, A. Riverola, J. Roca, J. Ramírez, P.D. Wagner, D. Ros, et al.
Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 149 (1994), pp. 423-429
[37.]
G. Cremona, T.W. Higenbottam, A.M. Wood, A.T. Dinh-Xuan.
Importance of endogeneous nitric oxide in the adaptation to increased blood flow in isolated human and sheep lungs.
Am Rev Rspir Dis, 145 (1992), pp. 206
[38.]
T. Higenbottam, G. Cremona.
Acute chronic hypoxic pulmonary hypertension.
Eur Respir J., 6 (1993), pp. 1.207-1.212
[39.]
J.P. Szidon.
The effect of COPD on pulmonary circulation.
Chronic obstructive pulmonary disease., pp. 101-110
[40.]
P. Pizcueta, J.M. Piqué, M. Fernández, J. Bosch, J. Rodés, B.J.R. Whitlle, et al.
Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition.
Gastroenterology, 103 (1992), pp. 1.909-1.915
[41.]
R. Rodríguez-Roisin, A.G.N. Agustí, J. Roca.
The hepatopulmonary syndrome: new name, old complexities.
Thorax, 47 (1992), pp. 897-902
[42.]
S. Adnot, C. Kouyoumdjian, C. Defouilloy, P. Andrivet, S. Sediame, R. Herigault, M.D. Fratacci.
Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension.
Am Rev Respir Dis, 148 (1993), pp. 310-316
[43.]
J. Mullol, C. Picado.
Neuropéptidos. Su papel en la fisiopatología respiratoria humana.
Arch Bronconeumol, 29 (1993), pp. 27-36
[44.]
J.L. Ellis, S.G. Farmer.
Effects of peptidases on nonadrenergic, noncolinergic inhibitory responses of tracheal smooth muscle, a comparison with effects on VIP-and PHI-induced relaxation.
Br J Pharmacol, 96 (1989), pp. 521-526
[45.]
C.G. Li, M.J. Rand.
Evidence that part of the NANC relaxant response of guinea-pig trachea to electrical fíeld stimulation is mediated by nitric oxide.
Br J Pharmacol, 102 (1991), pp. 91-94
[46.]
M. Hogman, C. Frostell, H. Arnberg, G. Hedenstierna.
Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit.
Eur Respir J, 6 (1993), pp. 177-180
[47.]
M. Hogman, C.G. Frostell, H. Hedenstrom, G. Hedenstierna.
Inhalation of nitric oxide modulates adult human bronchial tone.
Am Rev Respir Dis, 148 (1993), pp. 1.474-1.478
[48.]
P.G. Jorens, P.A. Vermeire, A.G. Herman.
L-arginine-dependent nitric oxide synthase: a new metabolic pathway in the lung and arways.
Eur Respir J, 6 (1993), pp. 258-266
[49.]
M.G. Belvisi, D. Stretton, P.J. Barnes.
Nitric oxide as an endogenous modulator of cholinergic neurotransmission in guinea-pig airways.
Eur J Pharmacol, 198 (1991), pp. 219-221
[50.]
P.J. Barnes, F.M. Cuss, J.B. Palmer.
The effect of airway epithelim on smooth muscle contractility in bovine trachea.
Br J Pharmacol, 86 (1985), pp. 685-691
[51.]
P.J. Barnes, M.G. Belvisi.
Nitric oxide and lung disease.
Thorax, 48 (1993), pp. 1.034-1.043
[52.]
S.A. Kharitonov, D. Yates, R.A. Robbins, R. Logan-Sinclair, E.A. Shinebourne, P.J. Barnes.
Increased nitric oxide in exhaled air of asthmathic patients.
Lancet, 343 (1994), pp. 133-135
[53.]
A. Petros, D. Bennett, P. Vallance.
Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock.
Lancet, 338 (1991), pp. 1.557-1.558
[54.]
H. Gerlach, D. Pappert, K. Lewandowski, R. Rossaint, K.J. Falke.
Long term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome.
Intensive Care Med, 19 (1993), pp. 443-449
[55.]
J.D. Roberts, P. Lang, L.M. Bigatello, G.J. Vlahakes, W.M. Zapol.
Inhaled nitric oxide in congenital heart disease.
Circulation, 87 (1993), pp. 447-453
[56.]
D.L. Wessel.
Inhaled nitric oxide for the treatment of pulmonary hypertension before and after cardiopulmonary bypass.
Crit Care Med, (1993), pp. 546-551
Copyright © 1994. Sociedad Española de Neumología y Cirugía Torácica
